Publicacions en què col·labora amb GABRIEL RUBIO VALLADOLID (12)

2023

  1. Associations of hypomagnesemia in patients seeking a first treatment of alcohol use disorder

    Drug and Alcohol Dependence, Vol. 245

  2. Sex differences in the comorbidity of patients seeking a first treatment for Alcohol Use Disorder

    International Journal of Mental Health and Addiction

2022

  1. Sex Differences in Plasma Lysophosphatidic Acid Species in Patients with Alcohol and Cocaine Use Disorders

    Brain Sciences, Vol. 12, Núm. 5

2021

  1. Plasma concentrations of lysophosphatidic acid and autotaxin in abstinent patients with alcohol use disorder and comorbid liver disease

    Biomedicines, Vol. 9, Núm. 9

2020

  1. Abstinent patients with alcohol use disorders show an altered plasma cytokine profile: Identification of both interleukin 6 and interleukin 17A as potential biomarkers of consumption and comorbid liver and pancreatic diseases

    Journal of Psychopharmacology, Vol. 34, Núm. 11, pp. 1250-1260

  2. Plasma tryptophan and kynurenine pathway metabolites in abstinent patients with alcohol use disorder and high prevalence of psychiatric comorbidity

    Progress in Neuro-Psychopharmacology and Biological Psychiatry, Vol. 102

2019

  1. Alcohol-induced cognitive deficits are associated with decreased circulating levels of the neurotrophin BDNF in humans and rats

    Addiction Biology, Vol. 24, Núm. 5, pp. 1019-1033

2018

  1. Higher impulsivity as a distinctive trait of severe cocaine addiction among individuals treated for cocaine or alcohol use disorders

    Frontiers in Psychiatry, Vol. 9, Núm. FEB

2017

  1. Comorbilidad psiquiátrica y valores plasmáticos de 2-acilgliceroles en consumidores de alcohol en tratamiento ambulatorio. Análisis de las diferencias de género

    Adicciones: Revista de socidrogalcohol, Vol. 29, Núm. 2, pp. 83-96

  2. Decreased plasma concentrations of BDNF and IGF-1 in abstinent patients with alcohol use disorders

    PLoS ONE, Vol. 12, Núm. 11

  3. Plasma chemokines in patients with alcohol use disorders: Association of CCL11 (Eotaxin-1) with psychiatric comorbidity

    Frontiers in Psychiatry, Vol. 7, Núm. JAN

  4. Plasma concentrations of oleoylethanolamide and other acylethanolamides are altered in alcohol-dependent patients: effect of length of abstinence

    Addiction Biology, Vol. 22, Núm. 5, pp. 1366-1377